pharmaphorum

MAY 23, 2022

The device will be worn by 2,000 people for a year, harvesting data on sleep status, heart rate, and activity levels, according to the study partners, which also include digital health and telemedicine firm MICIN and Tohoku University. ” The post Takeda, Daiichi-backed wearable study planned in Japan appeared first on.

Big Data 90

Big Data Genome Genomics Development 90

Drug Discovery World

JULY 3, 2024

DDW’s Megan Thomas talks to Nicola McCarthy, Head of Research at the Milner Therapeutics Institute. NM: I’m Head of Research at the Milner Therapeutics Institute, which is part of the University of Cambridge, and I oversee both wet and dry labs of the institute. MT: Can you provide a top-line summary of your research?

Big Data 52

Big Data Gene Nurses RNA 52

pharmaphorum

APRIL 8, 2022

This is where modern technologies and data-driven medical informatics can bridge gaps in RD research. . The webinar will also cover: How the necessary routine and research data can be collected in registries in a further processable form by patients and healthcare professionals.

Genome 55

Genome Genomics Research Big Data 55

Drug Discovery World

FEBRUARY 6, 2024

From finding potential active substances and identifying novel targets, to simulating how drugs will function in the human body and optimising laboratory workflows, digital technologies are having a significant impact on drug discovery and development. Universities are also using these digital technologies to advance their research.

Marketing 69

Marketing Medicine Genome Genomics 69

XTalks

APRIL 5, 2021

Bioinformaticians use a combination of mathematics, computer science and biology to help scientists make sense of the data gathered from research projects. The Human Genome Project could not have succeeded without the use of bioinformatics. The Human Genome Project could not have succeeded without the use of bioinformatics.

Bioinformatics 59

Bioinformatics Engineer Scientist Genome 59

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.

Genome 100

Genome Genomics Research Medicine 100

Drug Discovery World

DECEMBER 27, 2023

Developing. Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. DDW Highlights Innovative. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

Drug Discovery World

JULY 17, 2024

The findings, published in Nature , offer the first step in longed-for hope for the development of a treatment in the future. This discovery was initially made using data from the 100,000 Genomes Project, a study led by Genomics England and NHS England. The specific gene is called RNU4-2.

Genetics 52

Genetics Genome Project Genome Genomics 52

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. Figure 2: Advanced data visualisation examples for transcriptomics data.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

Delveinsight

FEBRUARY 17, 2021

Almost all the aspects of the healthcare sector, such as service delivery, communications, operation, medical equipment, and drug development, have grown remarkably and improved the overall health outcome. Improvement in the diagnostics, management of chronic conditions, drug and device development, are some of the key applications of AI.

Doctors 52

Doctors Doctor Big Data Development 52

The Pharma Data

JANUARY 4, 2021

Kiromic’s deep understanding of the tumor micro environment (TME) and the tumors’ escape and masking mechanisms led to development of a promising platform for chimeric antigen receptor therapy (CAR-T). PD-1 has always been a challenge for CAR-T development. “We believe Prof. About PD-1 Check-point inhibition.

In-Vivo 40

In-Vivo Development Big Data Immune Response 40

Drug Discovery World

SEPTEMBER 5, 2022

Throughout the continuum of drug development, from target discovery to patient selection, machine learning approaches are being adopted to reliably mine vast amounts of data and make predictions with higher accuracy Anita Ramanathan discusses how machine learning is currently used across different stages of cancer research. .

Development 52

Development Drugs Protein Genome 52

pharmaphorum

SEPTEMBER 18, 2020

The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin. “AstraZeneca will have a strong base for considerable expansion, especially in research and development and geographical presence. Zeneca Group plc.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

Drug Discovery World

SEPTEMBER 6, 2022

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year. . Thompson says that the development of Covid-19 vaccines, which used mRNA technology, resulted in wider acceptance for cell and gene therapies. . “On

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

Drug Discovery World

AUGUST 9, 2023

He spoke with DDW’s Megan Thomas about how AstraZeneca is innovating to displace chemotherapy and research areas of significance. Another area of research which is really exciting for the whole industry is genomics and genetically targeted medicines. MT: What developments have been most prolific in your career?

Drugs 52

Drugs Antibody Big Data Medicine 52

Drug Discovery World

FEBRUARY 9, 2023

Basic research and new technologies are uncovering insights every day that build on our understanding of human biology. I believe this is where the future of drug research and development hinges. On top of that, pharmaceutical development is extremely complex in itself.

Drugs 52

Drugs Development Big Data Scientist 52

Drug Discovery World

NOVEMBER 18, 2022

It states that whilst some antibiotic prescribing can be “appropriate when risks for related bacterial or fungal infections are unknown,” this level of high prescribing can “put patients at risk for side effects and create a pathway for resistance to develop and spread.” . Still, there are positive developments occurring within the sector.

Bacteria 52

Bacteria Drugs Development Research 52

Drug Discovery World

MAY 4, 2023

The potential of drug targets Over the next 50 years, new targets emerged and drugs were developed against them. The computational chemistry algorithms and force fields had developed in tandem with hardware, processors, parallel processing and supercomputers. Big data handling and machine learning made progress by leaps.

Medicine 52

Medicine Protein Drugs Bioassay 52

pharmaphorum

MARCH 16, 2021

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. AI use in the pandemic.

Doctors 106

Doctors Doctor Life Science Clinical Research 106

pharmaphorum

FEBRUARY 17, 2022

Researchers discovered a highly virulent variant of HIV in the Netherlands that genetic sequence analysis suggests has been circulating since the 1990s. . Identified as the “VB variant,” the virus has proved to be highly virulent and to speed up the progression of a patient developing AIDS faster. The VB variant.

Genome 89

Genome Genomics Genetics Genotype 89

The Pharma Data

JANUARY 17, 2021

There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. Syntegra has also engaged with the Federal Drug Administration (FDA) to evaluate the role of synthetic data in regulatory decisions, for COVID-19 and beyond. .

Life Science 52

Life Science Engineer Big Data Scientist 52